SEC Form D · filed May 24, 2024
IVIEW Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Xiaolu T. Sun · Cranbury, NJDirectorWei Wang · Cranbury, NJExec · DirectorBo Liang · Cranbury, NJExec · DirectorBin T. He · Cranbury, NJDirectorQi Zhu · Cranbury, NJDirectorJohn J. Baldwin · Cranbury, NJDirectorShafin Tejani · Vancouver, British Columbia, CanadaDirectorCarey Dillen · Vancouver, British Columbia, CanadaExec · DirectorSheri Rempel · Vancouver, British Columbia, CanadaDirectorKatrina Palanca · Vancouver, British Columbia, CanadaExec · DirectorMatthew Bailey · Vancouver, British Columbia, CanadaDirectorDavid Meltzer · Vancouver, British Columbia, CanadaDirectorTom T. Du · Cranbury, NJDirectorJoseph S. Saffire · SALT LAKE CITY, UTDirectorGary S. Crittenden · SALT LAKE CITY, UTExec · DirectorJoseph S. Bonner · SALT LAKE CITY, UTExec · DirectorDiane S. Olmstead · SALT LAKE CITY, UTDirectorSpencer S. Kirk · SALT LAKE CITY, UTDirectorMichael S. Rainen · Englewood, CODirectorTom T. Du · Cranbury, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗